Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
27359 | 231 | 24.6 | 51% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
316 | 3 | RHEUMATOLOGY//RHEUMATOID ARTHRITIS//RHEUMATOL | 39766 |
3663 | 2 | BUCILLAMINE//AZECINES//LE300 | 1171 |
27359 | 1 | BUCILLAMINE//ACTARIT//LOBENZARIT | 231 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | BUCILLAMINE | authKW | 2676770 | 16% | 56% | 36 |
2 | ACTARIT | authKW | 367184 | 2% | 56% | 5 |
3 | LOBENZARIT | authKW | 330464 | 2% | 50% | 5 |
4 | KE 298 | authKW | 297421 | 1% | 75% | 3 |
5 | CARRAGEENAN INDUCED COLITIS | authKW | 264375 | 1% | 100% | 2 |
6 | ESONARIMOD | authKW | 264375 | 1% | 100% | 2 |
7 | INTERNATIONAL JOURNAL OF IMMUNOTHERAPY | journal | 175361 | 11% | 5% | 25 |
8 | 2 ACETYLTHIOMETHYL 3 4 METHYLBENZOYLPROPIONIC ACID | authKW | 132188 | 0% | 100% | 1 |
9 | 2 ACETYLTHIOMETHYL 4 4 METHYLPHENYL 4 OXOBUTANOIC ACID | authKW | 132188 | 0% | 100% | 1 |
10 | 4 CHLORO 2 2 IMINODIBENZOIC ACID | authKW | 132188 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 1443 | 46% | 0% | 107 |
2 | Rheumatology | 1225 | 13% | 0% | 31 |
3 | Immunology | 851 | 30% | 0% | 69 |
4 | Chemistry, Medicinal | 88 | 6% | 0% | 15 |
5 | Allergy | 25 | 2% | 0% | 4 |
6 | Chemistry, Multidisciplinary | 23 | 10% | 0% | 22 |
7 | Cell Biology | 14 | 6% | 0% | 14 |
8 | Ophthalmology | 7 | 2% | 0% | 5 |
9 | Materials Science, Biomaterials | 3 | 1% | 0% | 2 |
10 | Transplantation | 1 | 1% | 0% | 2 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | HIGASHIHIYODOGAWA KU | 132188 | 0% | 100% | 1 |
2 | OMIYA TORY | 132188 | 0% | 100% | 1 |
3 | RHEUMATOLMEGURO KU | 132188 | 0% | 100% | 1 |
4 | CLIN MBC 03 65 | 66093 | 0% | 50% | 1 |
5 | PHARMACEUT SCI YAMADAOKA 16 | 66093 | 0% | 50% | 1 |
6 | BIOANAL MASS SPE OMETRY | 33045 | 0% | 25% | 1 |
7 | CENT BIOPHYS | 33043 | 1% | 13% | 2 |
8 | FARM QUIM ORGAN FARMACEUT | 14686 | 0% | 11% | 1 |
9 | NARA DEV | 10364 | 1% | 4% | 2 |
10 | PHARMACEUT S | 8052 | 3% | 1% | 7 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | INTERNATIONAL JOURNAL OF IMMUNOTHERAPY | 175361 | 11% | 5% | 25 |
2 | FOLIA PHARMACOLOGICA JAPONICA | 43423 | 8% | 2% | 19 |
3 | JOURNAL OF IMMUNOPHARMACOLOGY | 10462 | 2% | 2% | 4 |
4 | MODERN RHEUMATOLOGY | 5042 | 3% | 1% | 7 |
5 | INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY | 4166 | 3% | 0% | 8 |
6 | AGENTS AND ACTIONS | 3326 | 4% | 0% | 9 |
7 | JAPANESE JOURNAL OF PHARMACOLOGY | 3008 | 4% | 0% | 10 |
8 | DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH | 2574 | 3% | 0% | 6 |
9 | IMMUNOPHARMACOLOGY | 2479 | 2% | 0% | 5 |
10 | INTERNATIONAL JOURNAL OF TISSUE REACTIONS-EXPERIMENTAL AND CLINICAL ASPECTS | 2319 | 2% | 0% | 4 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BUCILLAMINE | 2676770 | 16% | 56% | 36 | Search BUCILLAMINE | Search BUCILLAMINE |
2 | ACTARIT | 367184 | 2% | 56% | 5 | Search ACTARIT | Search ACTARIT |
3 | LOBENZARIT | 330464 | 2% | 50% | 5 | Search LOBENZARIT | Search LOBENZARIT |
4 | KE 298 | 297421 | 1% | 75% | 3 | Search KE+298 | Search KE+298 |
5 | CARRAGEENAN INDUCED COLITIS | 264375 | 1% | 100% | 2 | Search CARRAGEENAN+INDUCED+COLITIS | Search CARRAGEENAN+INDUCED+COLITIS |
6 | ESONARIMOD | 264375 | 1% | 100% | 2 | Search ESONARIMOD | Search ESONARIMOD |
7 | 2 ACETYLTHIOMETHYL 3 4 METHYLBENZOYLPROPIONIC ACID | 132188 | 0% | 100% | 1 | Search 2+ACETYLTHIOMETHYL+3+4+METHYLBENZOYLPROPIONIC+ACID | Search 2+ACETYLTHIOMETHYL+3+4+METHYLBENZOYLPROPIONIC+ACID |
8 | 2 ACETYLTHIOMETHYL 4 4 METHYLPHENYL 4 OXOBUTANOIC ACID | 132188 | 0% | 100% | 1 | Search 2+ACETYLTHIOMETHYL+4+4+METHYLPHENYL+4+OXOBUTANOIC+ACID | Search 2+ACETYLTHIOMETHYL+4+4+METHYLPHENYL+4+OXOBUTANOIC+ACID |
9 | 4 CHLORO 2 2 IMINODIBENZOIC ACID | 132188 | 0% | 100% | 1 | Search 4+CHLORO+2+2+IMINODIBENZOIC+ACID | Search 4+CHLORO+2+2+IMINODIBENZOIC+ACID |
10 | 70 KDA HSPS | 132188 | 0% | 100% | 1 | Search 70+KDA+HSPS | Search 70+KDA+HSPS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | GONZALEZ, R , REMIREZ, D , (1997) CURRENT VIEWS ON THE PHARMACOLOGICAL PROPERTIES OF THE IMMUNOMODULATOR, LOBENZARIT DISODIUM.JOURNAL OF INVESTIGATIONAL ALLERGOLOGY & CLINICAL IMMUNOLOGY. VOL. 7. ISSUE 2. P. 77-82 | 25 | 66% | 1 |
2 | NOGUCHI, T , ONODERA, A , TOMISAWA, K , YAMASHITA, M , TAKESHITA, K , YOKOMORI, S , (2002) SYNTHESIS AND ANTIRHEUMATIC ACTIVITY OF THE METABOLITES OF ESONARIMOD.BIOORGANIC & MEDICINAL CHEMISTRY. VOL. 10. ISSUE 8. P. 2713-2721 | 10 | 67% | 4 |
3 | FUJISAWA, H , NISHIMURA, T , INOUE, Y , OGAYA, S , SHIBATA, Y , NAKAGAWA, Y , SATO, S , KIMURA, K , (1990) ANTIINFLAMMATORY PROPERTIES OF THE NEW ANTIRHEUMATIC AGENT 4-ACETYLAMINOPHENYLACETIC ACID.ARZNEIMITTELFORSCHUNG-DRUG RESEARCH. VOL. 40-1. ISSUE 6. P. 693-697 | 10 | 91% | 9 |
4 | KIM, SY , LEE, IH , BAE, SC , YOO, DH , (1995) PRELIMINARY TRIAL OF THE EFFICACY OF BUCILLAMINE IN KOREAN PATIENTS WITH RHEUMATOID-ARTHRITIS.CLINICAL DRUG INVESTIGATION. VOL. 9. ISSUE 5. P. 284-290 | 9 | 82% | 2 |
5 | INOUE, T , TAKESHITA, K , FUKUSHIMA, K , (2001) EFFECTS OF KE-758; AN ACTIVE METABOLITE OF THE NEW ANTI-RHEUMATIC DRUG KE-298, D-PENICILLAMINE, BUCILLAMINE AND AURANOFIN ON THE PROLIFERATION OF MURINE LYMPHOCYTES, AND THE PRODUCTION OF NITRIC OXIDE BY MURINE MACROPHAGES.INTERNATIONAL IMMUNOPHARMACOLOGY. VOL. 1. ISSUE 5. P. 833 -842 | 11 | 50% | 3 |
6 | KITANO, A , OSHITANI, N , OKABE, H , HARA, J , SUZUKI, N , AOKI, T , ADACHI, K , WATANABE, Y , YASUDA, K , TABATA, A , ET AL (1996) EFFECT OF BUCILLAMINE ON THE RAT TRINITROBENZENE SULFONIC ACID INDUCED MODEL OF COLITIS.INFLAMMATION RESEARCH. VOL. 45. ISSUE 10. P. 491-493 | 8 | 80% | 0 |
7 | NOGUCHI, T , ONODERA, A , TOMISAWA, K , YOKOMORI, S , (2002) SYNTHESIS OF DIHYDROTHIOPHENE DERIVATIVES AS METABOLITES OF ESONARIMOD.HETEROCYCLES. VOL. 57. ISSUE 10. P. 1907 -1914 | 6 | 86% | 0 |
8 | LEE, KC , CHUN, YG , KIM, I , SHIN, BS , PARK, ES , YOO, SD , YOUN, YS , (2009) DEVELOPMENT AND VALIDATION OF A REVERSED-PHASE FLUORESCENCE HPLC METHOD FOR DETERMINATION OF BUCILLAMINE IN HUMAN PLASMA USING PRE-COLUMN DERIVATIZATION WITH MONOBROMOBIMANE.JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES. VOL. 877. ISSUE 22. P. 2130 -2134 | 6 | 67% | 1 |
9 | NOGUCHI, T , HASEGAWA, M , TOMISAWA, K , MITSUKUCHI, M , (2003) SYNTHESIS AND STRUCTURE-ACTIVITY RELATIONSHIPS OF 5-PHENYLTHIOPHENECARBOXYLIC ACID DERIVATIVES AS ANTIRHEUMATIC AGENTS.BIOORGANIC & MEDICINAL CHEMISTRY. VOL. 11. ISSUE 22. P. 4729-4742 | 6 | 75% | 13 |
10 | HISADOME, M , KIMURA, Y , IKEGAMI, K , TERASAWA, M , (1988) EFFECT OF CYSTEINE ETHYLESTER HYDROCHLORIDE (CYSTANIN) ON HOST DEFENSE-MECHANISMS (IV) - POTENTIATING EFFECTS ON THE FUNCTION OF PERITONEAL OR SPLEEN MACROPHAGES.JAPANESE JOURNAL OF PHARMACOLOGY. VOL. 47. ISSUE 4. P. 379-385 | 8 | 100% | 0 |
Classes with closest relation at Level 1 |